
Pulmonx Corporation Common Stock
LUNG
LUNG: Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets.
moreShow LUNG Financials
Recent trades of LUNG by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by LUNG's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Collateral flow channel sealant delivery methods and systems Jul. 11, 2023
-
Patent Title: High resistance implanted bronchial isolation devices and methods Dec. 20, 2022
-
Patent Title: Methods and systems for endobronchial diagnosis Oct. 18, 2022
-
Patent Title: Methods and devices for passive residual lung volume reduction and functional lung volume expansion Aug. 16, 2022
-
Patent Title: Methods and systems for endobronchial diagnosis May. 03, 2022
-
Patent Title: Selective lung tissue ablation Apr. 19, 2022
-
Patent Title: Methods and devices for passive residual lung volume reduction and functional lung volume expansion Apr. 12, 2022
-
Patent Title: Implant loading device and system Aug. 10, 2021
-
Patent Title: Methods and systems for endobronchial diagnostics Mar. 02, 2021
-
Patent Title: Methods, systems, and devices for analyzing lung imaging data Dec. 22, 2020
-
Patent Title: High resistance implanted bronchial isolation devices and methods Sep. 01, 2020
-
Patent Title: Methods and devices for passive residual lung volume reduction and functional lung volume expansion Sep. 01, 2020
-
Patent Title: Devices and systems for lung treatment Aug. 18, 2020
-
Patent Title: Functional assessment and treatment catheters and methods for their use in the lung Dec. 31, 2019
-
Patent Title: Systems and methods for flushing an assessment catheter Nov. 19, 2019
-
Patent Title: Selective lung tissue ablation Nov. 12, 2019
-
Patent Title: Bronchial sealant delivery methods and systems Oct. 29, 2019
-
Patent Title: Collateral flow channel sealant delivery methods and systems Sep. 17, 2019
-
Patent Title: Method and apparatus for endobronchial diagnosis Sep. 17, 2019
-
Patent Title: Implant loading device and system Jul. 16, 2019
-
Patent Title: Methods and devices for passive residual lung volume reduction and functional lung volume expansion Jun. 11, 2019
-
Patent Title: Methods and systems for endobronchial diagnosis Jun. 11, 2019
-
Patent Title: Methods and systems for endobronchial diagnostics Sep. 18, 2018
-
Patent Title: Lung volume reduction therapy using crosslinked non-natural polymers Jun. 19, 2018
-
Patent Title: Implant loading device and system Jan. 23, 2018
-
Patent Title: Devices and systems for lung treatment Mar. 14, 2017
-
Patent Title: Methods and devices for passive residual lung volume reduction and functional lung volume expansion Jan. 03, 2017
-
Patent Title: Selective lung tissue ablation Nov. 08, 2016
-
Patent Title: Functional assessment and treatment catheters and methods for their use in the lung Sep. 13, 2016
-
Patent Title: Methods and systems for endobronchial diagnosis Jun. 14, 2016
-
Patent Title: Implant loading device and system Dec. 15, 2015
-
Patent Title: Pulmonary occlusal stent delivery catheter, loading system and methods of use Sep. 15, 2015
-
Patent Title: Measuring lung function and lung disease progression at a lobar/segmental level Aug. 18, 2015
-
Patent Title: Methods and devices for passive residual lung volume reduction and functional lung volume expansion Jun. 09, 2015
-
Patent Title: Collateral pathway treatment using agent entrained by aspiration flow current Nov. 04, 2014
-
Patent Title: Methods and systems for endobronchial diagnostics Aug. 19, 2014
-
Patent Title: Selective lung tissue ablation Oct. 29, 2013
-
Patent Title: Minimally invasive determination of collateral ventilation in lungs Sep. 03, 2013
-
Patent Title: Methods and devices for passive residual lung volume reduction and functional lung volume expansion Jul. 30, 2013
-
Patent Title: Implanted bronchial isolation devices and methods Jul. 02, 2013
-
Patent Title: Minimally invasive determination of collateral ventilation in lungs Jun. 04, 2013
-
Patent Title: Pulmonary occlusal stent delivery catheter, loading system and methods of use Apr. 02, 2013
-
Patent Title: Bronchial flow control devices and methods of use Mar. 05, 2013
-
Patent Title: Methods and devices for use in performing pulmonary procedures Jan. 22, 2013
-
Patent Title: Functional assessment and treatment catheters and methods for their use in the lung Jan. 01, 2013
-
Patent Title: Bronchial flow control devices with membrane seal Aug. 28, 2012
-
Patent Title: Methods and devices for blocking flow through collateral pathways in the lung Jun. 26, 2012
-
Patent Title: Methods, systems, and kits for lung volume reduction May. 15, 2012
-
Patent Title: Methods and systems for occluding collateral flow channels in the lung Mar. 20, 2012
-
Patent Title: Methods and devices to induce controlled atelectasis and hypoxic pulmonary vasoconstriction Mar. 20, 2012
Federal grants, loans, and purchases
- $53,530 2023-09-06 00:00:00 Agency: Department of Veterans Affairs
- $41,465 2023-08-16 00:00:00 Agency: Department of Veterans Affairs
- $13,500 2023-08-10 00:00:00 Agency: Department of Veterans Affairs
- $12,350 2023-07-27 00:00:00 Agency: Department of Veterans Affairs
- $29,500 2023-07-13 00:00:00 Agency: Department of Veterans Affairs
- $14,820 2023-06-28 00:00:00 Agency: Department of Veterans Affairs
- $18,880 2023-06-02 00:00:00 Agency: Department of Veterans Affairs
- $29,400 2023-05-23 00:00:00 Agency: Department of Veterans Affairs
- $12,350 2023-05-19 00:00:00 Agency: Department of Veterans Affairs
- $12,350 2023-04-26 00:00:00 Agency: Department of Veterans Affairs
- $12,350 2023-04-25 00:00:00 Agency: Department of Veterans Affairs
- $14,820 2023-04-24 00:00:00 Agency: Department of Veterans Affairs
- $12,350 2023-02-06 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $13,500 2023-01-05 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $11,800 2023-01-04 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $40,490 2022-11-23 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $11,250 2022-11-08 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $11,250 2022-11-03 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $11,250 2022-10-25 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $11,250 2022-09-19 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $11,250 2022-09-08 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $11,250 2022-09-08 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $11,500 2022-09-02 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $29,520 2022-08-23 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $13,500 2022-08-04 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $11,250 2022-07-20 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Followers on LUNG's company Twitter account
Number of mentions of LUNG in WallStreetBets Daily Discussion
Recent insights relating to LUNG
Recent picks made for LUNG stock on CNBC
ETFs with the largest estimated holdings in LUNG
Flights by private jets registered to LUNG